# CNB Financial Corp: financial statements, quarterly

CCNE · Nasdaq · CIK 736772 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/ccne.md) · [Financials](/companies/ccne/financials.md) · [Filings](/companies/ccne/filings.md) · [Insiders](/companies/ccne/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/ccne/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [28.3](/filings/0000736772-23-000072.md) | [31.5 d](/filings/0000736772-24-000044.md) | [32.7](/filings/0000736772-24-000061.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.4](/filings/0000736772-24-000108.md) | [3.2 d](/filings/0000736772-26-000031.md) | [2.8](/filings/0000736772-25-000087.md) | [3.0](/filings/0000736772-25-000169.md) | [3.3](/filings/0000736772-25-000202.md) | [3.6 d](/filings/0000736772-26-000031.md) | [2.9](/filings/0000736772-26-000053.md) | [3.3](/filings/0000736772-26-000075.md) | [2.0](/filings/0000736772-25-000202.md) | [8.1 d](/filings/0000736772-26-000031.md) | [6.1](/filings/0000736772-26-000053.md) | [6.9](/filings/0000736772-26-000075.md) |
| Net income | $m | [13.7](/filings/0000736772-24-000108.md) | [14.0 d](/filings/0000736772-26-000031.md) | [12.6](/filings/0000736772-26-000031.md) | [13.0](/filings/0000736772-26-000031.md) | [14.0](/filings/0000736772-26-000031.md) | [15.1](/filings/0000736772-26-000031.md) | [11.5](/filings/0000736772-26-000053.md) | [14.0](/filings/0000736772-26-000075.md) | [20.0](/filings/0000736772-26-000031.md) | [20.7](/filings/0000736772-26-000031.md) | [27.0](/filings/0000736772-26-000053.md) | [28.3](/filings/0000736772-26-000075.md) |
| Diluted EPS | $ per share | [0.60](/filings/0000736772-24-000108.md) | not reported | [0.55](/filings/0000736772-26-000031.md) | [0.56](/filings/0000736772-26-000031.md) | [0.61](/filings/0000736772-26-000031.md) | [0.66](/filings/0000736772-26-000031.md) | [0.50](/filings/0000736772-26-000053.md) | [0.61](/filings/0000736772-26-000075.md) | [0.69](/filings/0000736772-26-000031.md) | [0.66](/filings/0000736772-26-000031.md) | [0.88](/filings/0000736772-26-000053.md) | [0.91](/filings/0000736772-26-000075.md) |
| Basic EPS | $ per share | [0.60](/filings/0000736772-24-000108.md) | not reported | [0.55](/filings/0000736772-26-000031.md) | [0.57](/filings/0000736772-26-000031.md) | [0.61](/filings/0000736772-26-000031.md) | [0.67](/filings/0000736772-26-000031.md) | [0.50](/filings/0000736772-26-000053.md) | [0.61](/filings/0000736772-26-000075.md) | [0.69](/filings/0000736772-26-000031.md) | [0.67](/filings/0000736772-26-000031.md) | [0.88](/filings/0000736772-26-000053.md) | [0.92](/filings/0000736772-26-000075.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [183](/filings/0000736772-23-000072.md) | [222](/filings/0000736772-25-000071.md) | [301](/filings/0000736772-24-000061.md) | [331](/filings/0000736772-24-000086.md) | [361](/filings/0000736772-24-000108.md) | [443](/filings/0000736772-26-000031.md) | [520](/filings/0000736772-25-000087.md) | [425](/filings/0000736772-25-000169.md) | [438](/filings/0000736772-25-000202.md) | [528](/filings/0000736772-26-000075.md) | [602](/filings/0000736772-26-000053.md) | [458](/filings/0000736772-26-000075.md) |
| Total assets | $m | [5,732](/filings/0000736772-23-000072.md) | [5,753](/filings/0000736772-25-000071.md) | [5,801](/filings/0000736772-24-000061.md) | [5,887](/filings/0000736772-24-000086.md) | [6,015](/filings/0000736772-24-000108.md) | [6,192](/filings/0000736772-26-000031.md) | [6,296](/filings/0000736772-25-000087.md) | [6,318](/filings/0000736772-25-000169.md) | [8,254](/filings/0000736772-25-000202.md) | [8,396](/filings/0000736772-26-000075.md) | [8,515](/filings/0000736772-26-000053.md) | [8,432](/filings/0000736772-26-000075.md) |
| Total liabilities | $m | [5,183](/filings/0000736772-23-000072.md) | [5,182](/filings/0000736772-25-000071.md) | [5,223](/filings/0000736772-24-000061.md) | [5,300](/filings/0000736772-24-000086.md) | [5,408](/filings/0000736772-24-000108.md) | [5,581](/filings/0000736772-26-000031.md) | [5,671](/filings/0000736772-25-000087.md) | [5,681](/filings/0000736772-25-000169.md) | [7,410](/filings/0000736772-25-000202.md) | [7,524](/filings/0000736772-26-000075.md) | [7,626](/filings/0000736772-26-000053.md) | [7,523](/filings/0000736772-26-000075.md) |
| Long-term debt | $m | [84.2](/filings/0000736772-23-000072.md) | [84.3](/filings/0000736772-25-000071.md) | [84.3](/filings/0000736772-24-000061.md) | [84.4](/filings/0000736772-24-000086.md) | [84.5](/filings/0000736772-24-000108.md) | [84.6](/filings/0000736772-26-000031.md) | [84.6](/filings/0000736772-25-000087.md) | [84.7](/filings/0000736772-25-000169.md) | [84.8](/filings/0000736772-25-000202.md) | [84.9](/filings/0000736772-26-000075.md) | [85.0](/filings/0000736772-26-000053.md) | [35.0](/filings/0000736772-26-000075.md) |
| Short-term borrowings | $m | [0.0](/filings/0000736772-23-000072.md) | [0.0](/filings/0000736772-24-000061.md) | [0.0](/filings/0000736772-24-000061.md) | not reported | not reported | [0.0](/filings/0000736772-26-000031.md) | not reported | not reported | [182](/filings/0000736772-25-000202.md) | [164](/filings/0000736772-26-000075.md) | [164](/filings/0000736772-26-000053.md) | [164](/filings/0000736772-26-000075.md) |
| Shareholders' equity | $m | [549](/filings/0000736772-24-000108.md) | [571](/filings/0000736772-26-000031.md) | [579](/filings/0000736772-25-000169.md) | [587](/filings/0000736772-25-000202.md) | [606](/filings/0000736772-25-000202.md) | [611](/filings/0000736772-26-000075.md) | [625](/filings/0000736772-26-000075.md) | [637](/filings/0000736772-26-000075.md) | [844](/filings/0000736772-25-000202.md) | [872](/filings/0000736772-26-000075.md) | [889](/filings/0000736772-26-000075.md) | [909](/filings/0000736772-26-000075.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [12.9 d](/filings/0000736772-24-000108.md) | [17.7 d](/filings/0000736772-26-000031.md) | [12.5](/filings/0000736772-25-000087.md) | [10.4 d](/filings/0000736772-25-000169.md) | [26.4 d](/filings/0000736772-25-000202.md) | [22.2 d](/filings/0000736772-26-000031.md) | [11.6](/filings/0000736772-26-000053.md) | [20.2 d](/filings/0000736772-26-000075.md) | [7.1 d](/filings/0000736772-25-000202.md) | [26.1 d](/filings/0000736772-26-000031.md) | [19.2](/filings/0000736772-26-000053.md) | [36.9 d](/filings/0000736772-26-000075.md) |
| Capital expenditure | $m | [1.8 d](/filings/0000736772-24-000108.md) | [1.9 d](/filings/0000736772-26-000031.md) | [2.4](/filings/0000736772-25-000087.md) | [6.3 d](/filings/0000736772-25-000169.md) | [4.1 d](/filings/0000736772-25-000202.md) | [3.4 d](/filings/0000736772-26-000031.md) | [1.7](/filings/0000736772-26-000053.md) | [2.4 d](/filings/0000736772-26-000075.md) | [2.1 d](/filings/0000736772-25-000202.md) | [0.1 d](/filings/0000736772-26-000031.md) | [0.4](/filings/0000736772-26-000053.md) | [0.9 d](/filings/0000736772-26-000075.md) |
| Dividends paid | $m | [3.7 d](/filings/0000736772-24-000108.md) | [3.7 d](/filings/0000736772-26-000031.md) | [3.7](/filings/0000736772-25-000087.md) | [3.7 d](/filings/0000736772-25-000169.md) | [3.8 d](/filings/0000736772-25-000202.md) | [3.8 d](/filings/0000736772-26-000031.md) | [3.8](/filings/0000736772-26-000053.md) | [3.8 d](/filings/0000736772-26-000075.md) | [5.3 d](/filings/0000736772-25-000202.md) | [5.3 d](/filings/0000736772-26-000031.md) | [5.6](/filings/0000736772-26-000053.md) | [5.6 d](/filings/0000736772-26-000075.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.3](/filings/0000736772-23-000072.md) | [21.1](/filings/0000736772-24-000061.md) | [21.0](/filings/0000736772-24-000086.md) | [20.9](/filings/0000736772-24-000108.md) | [20.9](/filings/0000736772-25-000087.md) | [20.9](/filings/0000736772-25-000169.md) | [20.9](/filings/0000736772-25-000202.md) | [20.9](/filings/0000736772-26-000053.md) | [21.0](/filings/0000736772-26-000075.md) | [27.3](/filings/0000736772-25-000202.md) | [29.4](/filings/0000736772-26-000053.md) | [29.5](/filings/0000736772-26-000075.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 29,620,885 at 2026-08-05, from the cover of the [10-Q filed 2026-08-05](/filings/0000736772-26-000075.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:23 ET. No prices; not investment advice.